Loading...
Docoh

Prospector Capital (PRSR)

Document And Entity Information

Document And Entity Information - shares6 Months Ended
Jun. 30, 2021Aug. 16, 2021
Document Information Line Items
Entity Registrant NamePROSPECTOR
CAPITAL CORP.
Trading SymbolPRSR
Document Type10-Q
Current Fiscal Year End Date--12-31
Amendment Flagfalse
Entity Central Index Key0001825473
Entity Current Reporting StatusYes
Entity Filer CategoryNon-accelerated Filer
Document Period End DateJun. 30,
2021
Document Fiscal Year Focus2021
Document Fiscal Period FocusQ2
Entity Small Businesstrue
Entity Emerging Growth Companytrue
Entity Shell Companytrue
Entity Ex Transition Periodfalse
Document Quarterly Reporttrue
Document Transition Reportfalse
Entity File Number001-39854
Entity Incorporation, State or Country CodeE9
Entity Tax Identification Number00-0000000
Entity Address, Address Line One1250
Prospect Street
Entity Address, Address Line TwoSuite 200
Entity Address, City or TownLa
Jolla
Entity Address, State or ProvinceCA
Entity Address, Postal Zip Code92037
City Area Code(650)
Local Phone Number396-7700
Title of 12(b) SecurityClass A ordinary shares, par value $0.0001 per share
Security Exchange NameNASDAQ
Entity Interactive Data CurrentYes
Class A Ordinary Shares
Document Information Line Items
Entity Common Stock, Shares Outstanding32,500,000
Class B Ordinary Shares
Document Information Line Items
Entity Common Stock, Shares Outstanding8,125,000

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)Jun. 30, 2021Dec. 31, 2020
Current assets
Cash $ 748,858 $ 7,647,736
Prepaid expenses274,850
Total Current Assets1,023,708 7,647,736
Deferred offering costs 444,204
Investments held in Trust Account325,008,631
TOTAL ASSETS326,032,339 8,091,940
Current liabilities
Accounts payable and accrued expenses157,273
Due to Sponsor199
Accrued offering costs 311,940
Promissory note – related party 10,000
Total Current Liabilities157,472 321,940
Warrant liabilities 2,790,000
Deferred underwriting fee payable11,375,000
Total Liabilities11,532,472 3,111,940
Commitments and Contingencies
Class A ordinary shares subject to possible redemption 30,949,986 and no shares at $10.00 per share redemption value at June 30, 2021 and December 31, 2020309,499,860
Shareholders’ Equity
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 1,550,014 and no shares issued and outstanding (excluding 30,949,986 and no shares subject to possible redemption) at June 30, 2021 and December 31, 2020, respectively (1)[1]155
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 8,125,000 and 8,625,000 shares issued and outstanding at June 30, 2021 and December 31, 2020, respectively (1)[1]813 863
Additional paid-in capital8,625,728 4,984,137
Accumulated deficit(3,626,689)(5,000)
Total Shareholders’ Equity5,000,007 4,980,000
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $ 326,032,339 $ 8,091,940
[1]At
December 31, 2020, included up to 1,125,000 shares subject to forfeiture if the over-allotment option was not exercised in full or in
part by the underwriters (see Note 5). As a result of the underwriters’ election to partially exercise their over-allotment option
on January 12, 2021 and the forfeiture of the remaining option, 500,000 Class B ordinary shares were forfeited and there are now 8,125,000
Class B ordinary shares issued and outstanding (see Note 5).

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parentheticals) - $ / shares3 Months Ended6 Months Ended
Dec. 31, 2020Jun. 30, 2021
Class A ordinary shares subject to possible redemption0 30,949,986
Class A ordinary shares subject to per share redemption value (in Dollars per share) $ 10 $ 10
Preference shares, par value (in Dollars per share) $ 0.0001 $ 0.0001
Preference shares, shares authorized1,000,000 1,000,000
Preference shares, shares issued
Preference shares, shares outstanding
Class A Ordinary Shares
Ordinary shares, par value (in Dollars per share) $ 0.0001 $ 0.0001
Ordinary shares, shares authorized200,000,000 200,000,000
Ordinary shares, shares issued 1,550,014
Ordinary shares, shares outstanding 1,550,014
Class B Ordinary Shares
Ordinary shares, par value (in Dollars per share) $ 0.0001 $ 0.0001
Ordinary shares, shares authorized20,000,000 20,000,000
Ordinary shares, shares issued8,625,000 8,125,000
Ordinary shares, shares outstanding8,625,000 8,125,000

Condensed Statements of Operati

Condensed Statements of Operations (Unaudited) - USD ($)3 Months Ended6 Months Ended
Jun. 30, 2021Jun. 30, 2021
Income Statement [Abstract]
General and administrative expenses $ 297,107 $ 636,986
Loss from operations(297,107)(636,986)
Other income (expense):
Interest earned on investments held in Trust Account4,940 8,631
Change in fair value of warrant liabilities736,666 (2,993,334)
Total other income (expense), net741,606 (2,984,703)
Net income (loss) $ 444,499 $ (3,621,689)
Weighted average shares outstanding, Class A redeemable ordinary shares (in Shares)32,500,000 32,500,000
Basic and diluted net income per share, Class A redeemable ordinary shares (in Dollars per share) $ 0 $ 0
Weighted average shares outstanding, Class B non-redeemable ordinary shares (in Shares)8,125,000 8,076,657
Basic and diluted net income (loss) per share, Class B non-redeemable ordinary shares (in Dollars per share) $ 0.05 $ (0.45)

Condensed Statement of Changes

Condensed Statement of Changes in Shareholders’ Equity (Unaudited) - USD ($)Class AOrdinary Shares(1)Class BOrdinary Shares(1)Additional Paid-in CapitalAccumulated DeficitTotal
Balance at Dec. 31, 2020 $ 863 [1] $ 4,984,137 $ (5,000) $ 4,980,000
Balance (in Shares) at Dec. 31, 2020 8,625,000 [1]
Sale of 32,500,000 Units, net of underwriting discounts $ 3,250 [1]306,604,972 $ 306,608,222
Sale of 32,500,000 Units, net of underwriting discounts (in Shares)32,500,000 [1]2,583,333
Sale of 750,000 Private Placement Warrants, net of warrant liability [1]220,000 $ 220,000
Forfeiture of Founder Shares $ (50)[1]50
Forfeiture of Founder Shares (in Shares)[1](500,000)
Cancellation of 2,583,333 private placement warrants [1]930,000 930,000
Change in value of Class A Ordinary shares subject to possible redemption $ (3,037) [1](303,668,993) (303,672,030)
Change in value of Class A Ordinary shares subject to possible redemption (in Shares)(30,367,203) [1]
Net income (loss) [1] (4,066,188)(4,066,188)
Balance at Mar. 31, 2021 $ 213 $ 813 [1]9,070,166 (4,071,188)5,000,004
Balance (in Shares) at Mar. 31, 20212,132,797 8,125,000 [1]
Change in value of Class A Ordinary shares subject to possible redemption $ (58) [1](5,827,772) (5,827,830)
Change in value of Class A Ordinary shares subject to possible redemption (in Shares)(582,783) [1]
Transfer of private warrants to equity [1]5,383,334 5,383,334
Net income (loss) [1] 444,499 444,499
Balance at Jun. 30, 2021 $ 155 $ 813 [1] $ 8,625,728 $ (3,626,689) $ 5,000,007
Balance (in Shares) at Jun. 30, 20211,550,014 8,125,000 [1]
[1]At
December 31, 2020, included up to 1,125,000 shares subject to forfeiture if the over-allotment option was not exercised in full or in
part by the underwriters (see Note 5). As a result of the underwriters’ election to partially exercise their over-allotment option
on January 12, 2021 and the forfeiture of the remaining option, 500,000 Class B ordinary shares were forfeited and there are now 8,125,000
Class B ordinary shares issued and outstanding (see Note 5).

Condensed Statement of Change_2

Condensed Statement of Changes in Shareholders’ Equity (Unaudited) (Parentheticals)3 Months Ended
Mar. 31, 2021shares
Statement of Stockholders' Equity [Abstract]
Sale of units, net of underwriting discounts32,500,000
Sale of Private Placement Warrants750,000
Net of the return of Private Placement Warrants2,583,333

Condensed Statement of Cash Flo

Condensed Statement of Cash Flows (Unaudited)6 Months Ended
Jun. 30, 2021USD ($)
Cash Flows from Operating Activities:
Net loss $ (3,621,689)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on investments held in Trust Account(8,631)
Change in fair value of warrant liabilities2,993,334
Changes in operating assets and liabilities:
Prepaid expenses(274,850)
Accounts payable and accrued expenses157,273
Net cash used in operating activities(754,563)
Cash Flows from Investing Activities:
Investment of cash in Trust Account(325,000,000)
Net cash used in investing activities(325,000,000)
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid318,500,000
Proceeds from sale of Private Placement Warrants750,000
Due to Sponsor199
Repayment of promissory note – related party(10,000)
Payment of offering costs(384,514)
Net cash provided by financing activities318,855,685
Net Change in Cash(6,898,878)
Cash – Beginning of period7,647,736
Cash – End of period748,858
Non-Cash investing and financing activities:
Deferred underwriting fee payable11,375,000
Initial classification of Class A ordinary shares subject to possible redemption310,128,220
Change in value of Class A ordinary shares subject to possible redemption(628,360)
Forfeiture of Founder Shares(50)
Transfer of private warrant liabilities to equity $ (5,383,334)

Description of Organization and

Description of Organization and Business Operations6 Months Ended
Jun. 30, 2021
Accounting Policies [Abstract]
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONSNOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS
OPERATIONS Prospector Capital Corp. (the “Company”)
is a blank check company incorporated as a Cayman Islands exempted company on September 18, 2020. The Company was incorporated for the
purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with
one or more businesses or entities (a “Business Combination”). The Company is not limited to a particular industry
or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such,
the Company is subject to all of the risks associated with early stage and emerging growth companies. As of June 30, 2021, the Company had not commenced
any operations. All activity for the period from September 18, 2020 (inception) through June 30, 2021 relates to the Company’s formation
and the initial public offering (“Initial Public Offering”), which is described below, and subsequent to the Initial Public
Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the
completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from
the proceeds derived from the Initial Public Offering. The registration statement for the Company’s
Initial Public Offering was declared effective on January 7, 2021. On January 12, 2021, the Company consummated the Initial Public Offering
of 32,500,000 units (the “Units”), which includes the partial exercise by the underwriter of its over-allotment option in
the amount of 2,500,000 Units, at $10.00 per Unit, generating gross proceeds of $325,000,000 which is described in Note 3. Transaction costs amounted to $18,391,778, consisting
of $6,500,000 of underwriting fees, $11,375,000 of deferred underwriting fees and $516,778 of other offering costs. Following the closing of the Initial Public Offering
on January 12, 2021, an amount of $325,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public
Offering and the sale of the private placement warrants (the “Private Placement Warrants”) was placed in a trust account (the
“Trust Account”), and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the
Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less, or in
any open-ended investment company that holds itself out as a money market fund investing solely in U.S. Treasuries and meeting certain
conditions under Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earliest of: (i) the completion
of a Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described
below. The Company’s management has broad discretion
with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants,
although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The stock
exchange listing rules require that the Business Combination must be with one or more operating businesses or assets with a fair market
value equal to at least 80% of the assets held in the Trust Account (excluding the amount of deferred underwriting commissions and taxes
payable on the interest earned on the Trust Account). The Company will only complete a Business Combination if the post-Business Combination
company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling
interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company
Act. There is no assurance that the Company will be able to successfully effect a Business Combination. The Company will provide the holders of the public
shares (the “Public Shareholders” and, with respect to the Class A ordinary shares included in the Units being offered, the
“Public Shares”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of the Business
Combination, either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of
a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer
will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares, equal to
the aggregate amount then on deposit in the Trust Account, calculated as of two business days prior to the consummation of the Business
Combination (initially anticipated to be $10.00 per Public Share), including interest (which interest shall be net of taxes payable),
divided by the number of then issued and outstanding public shares, subject to certain limitations as described in the prospectus. The
per-share amount to be distributed to the Public Shareholders who properly redeem their shares will not be reduced by the deferred underwriting
commissions the Company will pay to the underwriters (as discussed in Note 5). There will be no redemption rights upon the completion
of a Business Combination with respect to the Company’s warrants. The Company will proceed with a Business Combination
only if the Company has net tangible assets of at least $5,000,001 and, if the Company seeks shareholder approval, it receives an ordinary
resolution under Cayman Islands law approving a Business Combination, which requires the affirmative vote of a majority of the shareholders
who attend and vote at a general meeting of the Company. If a shareholder vote is not required and the Company does not decide to hold
a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles
of Association, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”),
and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior
to completing a Business Combination. If the Company seeks shareholder approval in connection with a Business Combination, Prospector
Sponsor LLC (the “Sponsor”) has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during
or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each Public Shareholder may elect to
redeem their Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against a proposed Business
Combination. Notwithstanding the foregoing, if the Company
seeks shareholder approval of the Business Combination and the Company does not conduct redemptions pursuant to the tender offer rules,
a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert
or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares without
the Company’s prior written consent. The Sponsor has agreed (a) to waive its redemption
rights with respect to any Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and
(b) not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (i) to modify the substance
or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or
to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined
below) or (ii) with respect to any other provision relating to shareholders’ rights or pre-initial business combination activity,
unless the Company provides the Public Shareholders with the opportunity to redeem their Public Shares upon approval of any such amendment
at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on
the Trust account and not previously released to pay taxes, divided by the number of then issued and outstanding Public Shares. The Company will have until January 12, 2023 to
consummate a Business Combination (the “Combination Period”). However, if the Company has not completed a Business Combination
within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly
as reasonably possible but not more than ten business days thereafter, redeem 100% of the Public Shares, at a per-share price, payable
in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned and not previously released to
us to pay our taxes, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding
Public Shares, which redemption will completely extinguish the rights of the Public Shareholders as shareholders (including the right
to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject
to the approval of the Company’s remaining Public Shareholders and its Board of Directors, liquidate and dissolve, subject in each
case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable
law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless
if the Company fails to complete a Business Combination within the Combination Period. The Sponsor has agreed to waive its rights to
liquidating distributions from the Trust Account with respect to the Founder Shares it will receive if the Company fails to complete a
Business Combination within the Combination Period. However, if the Sponsor or any of its respective affiliates acquire Public Shares,
such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination
within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note
5) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period, and in such
event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the
Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution
will be less than the Initial Public Offering price per Unit ($10.00). In order to protect the amounts held in the Trust
Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the
Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective
target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account
to below the lesser of (1) $10.00 per Public Share and (2) the actual amount per Public Share held in the Trust Account as of
the date of the liquidation of the Trust Account, if less than $10.00 per Public Share, due to reductions in the value of trust assets,
in each case net of the interest that may be withdrawn to pay taxes. This liability will not apply to any claims by a third party who
executed a waiver of any and all rights to seek access to the Trust Account and as to any claims under the Company’s indemnity of
the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as
amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party,
the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility
that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers
(other than the Company’s independent registered public accounting firm), prospective target businesses or other entities with which
the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies
held in the Trust Account. Liquidity and Capital Resources As of June 30, 2021, the Company had $748,858
in its operating bank accounts and working capital of $866,236. In order to finance transaction costs in connection with a Business Combination,
the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide
the Company Working Capital Loans (see Note 4). As of June 30, 2021 and December 31, 2020, there were no amounts outstanding under any
Working Capital Loans. The Company may raise additional capital through
loans or additional investments from the Sponsor or its shareholders, officers, directors, or third parties. The Company’s officers
and directors and the Sponsor may but are not obligated to (except as described above), loan the Company funds, from time to time, in
whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Based on the foregoing,
the Company believes it will have sufficient working capital and borrowing capacity from the Sponsor or an affiliate of the Sponsor, or
certain of the Company’s officers and directors to meet its needs through the earlier of the consummation of a Business Combination
or at least one year from the date that the financial statements were issued.

Summary of Significant Accounti

Summary of Significant Accounting Policies6 Months Ended
Jun. 30, 2021
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIESNOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed financial
statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”)
for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain
information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or
omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information
and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management,
the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are
necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial
statements should be read in conjunction with the Company’s Annual Report on Form 10-K, as amended on July 26, 2021, for the period
ended December 31, 2020. The interim results for the three and six months ended June 30, 2021 are not necessarily indicative of the results
to be expected for the year ending December 31, 2021 or for any future periods. Emerging Growth Company The Company is an “emerging growth company,”
as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”),
and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that
are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting
firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation
in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive
compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts
emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that
is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered
under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company
can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but
any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that
when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging
growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison
of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth
company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting
standards used. Use of Estimates The preparation of the condensed financial statements
in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of
assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts
of revenues and expenses during the reporting period. Making estimates requires management to exercise
significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances
that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near
term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed financial
statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information
becomes available and accordingly the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments
with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents
as of June 30, 2021 and December 31, 2020. Offering Costs Offering costs consisted of legal, accounting
and other expenses incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs
were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared
to total proceeds received. Offering costs associated with warrant liabilities were expensed as incurred in the condensed statements of
operations. Offering costs associated with the Class A ordinary shares issued were charged to shareholders’ equity upon the completion
of the Initial Public Offering. Offering costs amounting to $18,391,778 were charged to shareholders’ equity upon the completion
of the Initial Public Offering. The Company’s deferred underwriting commissions are classified as non-current liabilities as their
liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. Class A Ordinary Shares Subject to Possible
Redemption The Company accounts for its Class A ordinary
shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480
“Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption are classified as a liability
instrument and are measured at redemption value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption
rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within
the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’
equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s
control and subject to occurrence of uncertain future events. Accordingly, at June 30, 2021, Class A ordinary shares subject to possible
redemption are presented as temporary equity, outside of the shareholders’ equity section of the Company’s condensed balance
sheet. Warrant Liabilities The Company does not use derivative instruments
to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including
issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives,
pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The Company accounts for the
Public Warrants and Private Placement Warrants (together with the Public Warrants, the “Warrants”) in accordance with the
guidance contained in ASC 815-40. Previously, the Private Placement Warrants did not meet the criteria for equity treatment and were recorded
as liabilities. Accordingly, the Company classified the Private Placement Warrants as liabilities at their fair value and adjusted the
Private Placement Warrants to fair value at each reporting period. This liability was subject to re-measurement at each balance sheet
date until exercised, and any change in fair value was recognized in our statements of operations. The Private Placement Warrants for
periods where no observable traded price was available were valued using a Modified Black-Scholes model. As of June 30, 2021, the Company
executed an agreement whereby the holders of the private warrants will not transfer their warrants to non-affiliated holders. The private
warrants are now considered to be indexed to the Company’s ordinary shares in the manner contemplated by ASC Section 815-40-15 and
therefore qualify for equity treatment. Income Taxes The Company accounts for income taxes under ASC
Topic 740, “Income Taxes,” which prescribes a recognition threshold and a measurement attribute for the financial statement
recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax
position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined
that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to
unrecognized tax benefits as income tax expense. As of June 30, 2021 and December 31, 2020, there were no unrecognized tax benefits and
no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant
payments, accruals or material deviation from its position. The Company’s management does not expect the total amount of unrecognized
tax benefits will materially change over the next twelve months. The Company is considered to be an exempted Cayman
Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing
requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented. Net income (Loss) per Ordinary Share Net income (loss) per ordinary share is computed
by dividing net income (loss) by the weighted average number of ordinary shares outstanding for the period. The calculation of diluted
income (loss) per share does not consider the effect of the warrants issued in connection with the Initial Public Offering and the private
placement , since the average stock price of the Company’s ordinary shares for the three and six months ended June 30, 2021 was less
than the exercise price and therefore, the inclusion of such warrants under the treasury stock method would be anti-dilutive. The Company’s statements of operations include
a presentation of income (loss) per share for ordinary shares subject to possible redemption in a manner similar to the two-class method
of income (loss) per ordinary share. Net income (loss) per ordinary share, basic and diluted, for Class A redeemable ordinary shares is
calculated by dividing the interest income earned on the Trust Account, by the weighted average number of Class A redeemable ordinary
shares outstanding since original issuance. Net income (loss) per share, basic and diluted, for Class B non-redeemable ordinary shares
is calculated by dividing the net income (loss), adjusted for income attributable to Class A redeemable ordinary shares, by the weighted
average number of Class B non-redeemable ordinary shares outstanding for the period. Class B non-redeemable ordinary shares includes the
Founder Shares as these shares do not have any redemption features and do not participate in the income earned on the Trust Account. The following table reflects the calculation of
basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts):
Three Months Six Months June 30,
2021 2021
Redeemable Class A Ordinary Shares
Numerator: Earnings allocable to Redeemable Class A Ordinary Shares
Interest Income $ 4,940 $ 8,631
Redeemable Net Earnings $ 4,940 $ 8,631
Denominator: Weighted Average Redeemable Class A Ordinary Shares (1)
Redeemable Class A Ordinary Shares, Basic and Diluted 32,500,000 32,500,000
Earnings/Basic and Diluted Redeemable Class A Ordinary Shares $ 0.00 $ 0.00
Non-Redeemable Class A and B Ordinary Shares
Numerator: Net Income (Loss) minus Redeemable Net Earnings
Net Income (Loss) $ 444,499 $ (3,621,689 )
Less: Redeemable Net Earnings (4,940 ) (8,631 )
Non-Redeemable Net Income (Loss) $ 439,559 $ (3,630,320 )
Denominator: Weighted Average Non-Redeemable B Ordinary Shares
Non-Redeemable B Ordinary Shares, Basic and Diluted 8,125,000 8,076,657
Basic and Diluted Net Income (Loss) Per Share, Non-Redeemable Class A and
B Ordinary Shares $ 0.05 $ (0.45 )
(1) For the three and six months ended June 30, 2021, basic and diluted
ordinary shares are the same as there are no non-redeemable securities that are dilutive to the Company’s shareholders. Concentration of Credit Risk Financial instruments that potentially subject
the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal
Depository Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on these accounts and management believes
the Company is not exposed to significant risks on such account. Fair Value of Financial Instruments The fair value of the Company’s financial
assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale
of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the
measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of
observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions
about how market participants would price assets and liabilities). Carrying values for prepaids, accounts payable and accrued expenses
approximate fair value. The following fair value hierarchy is used to
classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. Derivative Financial Instruments The Company evaluates its financial instruments
to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic
815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative
instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the
fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments
should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified
in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required
within 12 months of the balance sheet date. Recent Accounting Standards In August 2020, the Financial Accounting Standards
Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other
Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”)
to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial
conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining
to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible
debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings
per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is for fiscal
years beginning after December 15, 2021 and should be applied on a full or modified retrospective basis. Early adoption is permitted,
but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company is
currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows. Management does not believe that any other recently
issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed
financial statements.

Initial Public Offering

Initial Public Offering6 Months Ended
Jun. 30, 2021
Initial Public Offering Disclosure [Abstract]
INITIAL PUBLIC OFFERINGNOTE 3. INITIAL PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company
sold 32,500,000 Units, which includes a partial exercise by the underwriters of their over-allotment option in the amount of 2,500,000
Units, at a purchase price of $10.00 per Unit. Each Unit consists of one Class A ordinary share and one-third of one redeemable warrant
(“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at an exercise
price of $11.50 per whole share (see Note 7).

Related Party Transactions

Related Party Transactions6 Months Ended
Jun. 30, 2021
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONSNOTE 4. RELATED PARTY TRANSACTIONS Founder Shares and Private Placement Warrants On September 28, 2020, pursuant to a Securities
Purchase Agreement, the Sponsor purchased 10,062,500 Class B ordinary shares (the “Founder Shares”) and 10,050,000 Private
Placement Warrants for an aggregate purchase price of $10,075,000. On December 16, 2020, pursuant to the Securities Purchase Agreement
Amendment (the “SPA Amendment”), the Sponsor returned 2,875,000 Founder Shares and 2,300,000 Private Placement Warrants to
the Company for $2,300,000. In January 2021, the Sponsor forfeited an additional 2,583,333 Private Placement Warrants for no consideration,
resulting in 7,187,500 Founder Shares and 5,166,667 Private Placement Warrants outstanding. On January 7, 2021, the Company effected a
1:1.2 share capitalization of its Class B ordinary shares, resulting in an aggregate of 8,625,000 Founder Shares outstanding, all of which
are held by the Sponsor. Simultaneously with the closing of the Initial
Public Offering, the Sponsor purchased an aggregate of 500,000 Private Placement Warrants for an aggregate purchase price of $750,000,
or $1.50 per Private Placement Warrant. The Founder Shares included an aggregate of up
to 1,125,000 shares that were subject to forfeiture in the event that, and to the extent to which, the underwriters’ option to purchase
additional Units was exercised, so that the number of Founder Shares would equal, on an as-converted basis, 20% of the Company’s
issued and outstanding ordinary shares after the Initial Public Offering. As a result of the underwriters’ election to partially
exercise their over-allotment option and the forfeiture of the remaining option, 500,000 Founder Shares were forfeited and there are now
8,125,000 Class B ordinary shares issued and outstanding. Each Private Placement Warrant is exercisable
to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 7). A portion of the proceeds
from the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company
does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants will
be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants
will expire worthless. The Sponsor has agreed, subject to limited exceptions,
not to transfer, assign or sell any of the Founder Shares until the earliest of: (A) one year after the completion of a Business
Combination and (B) subsequent to a Business Combination, (x) if the closing price of the Class A ordinary shares equals
or exceeds $12.00 per share (as adjusted for share sub-divisions, share dividends, rights issuances, reorganizations, recapitalizations
and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination,
or (y) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in
all of the Public Shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property. Administrative Services Agreement The Company entered into an agreement, commencing
on January 7, 2021 through the earlier of the consummation of a Business Combination or the Company’s liquidation, to pay the Sponsor
a monthly fee of $10,000 for office space, utilities, secretarial and administrative services. For the three and six months ended June
30, 2021, the Company incurred and paid $30,000 and $60,000 in fees for these services, respectively. At June 30, 2021 and December 31,
2020, there were $60,000 included in accounts payable and accrued expenses in the accompanying condensed balance sheet. There were no
amounts included in accrued expenses at December 31, 2020. Promissory Note — Related Party On September 18, 2020, the Company issued an unsecured
promissory note (the “Promissory Note”) to the Sponsor, pursuant to which the Company could borrow up to an aggregate principal
amount of $300,000. The Promissory Note was non-interest bearing and payable on the earlier of (i) June 30, 2021 and (ii) the
completion of the Initial Public Offering. The outstanding amount of $10,000 was repaid on January 22, 2021. Borrowings under the Promissory
Note are no longer available. Related Party Loans In order to finance transaction costs in connection
with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may,
but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a
Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company.
Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination
does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds
held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital
Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either
be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such
Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.50 per warrant. The warrants
would be identical to the Private Placement Warrants. As of June 30, 2021 and December 31, 2020, there were no amounts outstanding under
the Working Capital Loans.

Commitments and Contingencies

Commitments and Contingencies6 Months Ended
Jun. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIESNOTE 5. COMMITMENTS AND CONTINGENCIES Risks and Uncertainties Management continues to evaluate the impact of
the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s
financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of
the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of
this uncertainty. Registration Rights Pursuant to a registration and shareholders rights
agreement entered into on January 7, 2021, the holders of the Founder Shares, Private Placement Warrants and any warrants that may be
issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement
Warrants and warrants that may be issued upon conversion of the Working Capital Loans) will have registration rights to require the Company
to register a sale of any of the securities held by them. The holders of these securities are entitled to make up to three demands, excluding
short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration
rights with respect to registration statements filed subsequent to the completion of a Business Combination. The registration rights agreement
does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’s securities.
The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters are entitled to a deferred fee
of $0.35 per Unit, or $11,375,000 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in
the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

Shareholders' Equity

Shareholders' Equity6 Months Ended
Jun. 30, 2021
Stockholders' Equity Note [Abstract]
SHAREHOLDERS’ EQUITYNOTE 6. SHAREHOLDERS’ EQUITY Preference Shares Class A Ordinary Shares Class B Ordinary Shares Holders of Class A ordinary shares and Class B
ordinary shares will vote together as a single class on all other matters submitted to a vote of shareholders, except as required by law. The Class B ordinary shares will automatically
convert into Class A ordinary shares concurrently with or immediately following the consummation of a Business Combination on a one-for-one
basis, subject to adjustment. In the case that additional Class A ordinary shares or equity-linked securities are issued or deemed
issued in connection with a Business Combination, the number of Class A ordinary shares issuable upon conversion of all Founder Shares
will equal, in the aggregate, 20% of the total number of Class A ordinary shares outstanding after such conversion (after giving
effect to any redemptions of Class A ordinary shares by Public Shareholders), including the total number of Class A ordinary
shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued,
by the Company in connection with or in relation to the consummation of a Business Combination, excluding any Class A ordinary shares
or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller in
a Business Combination and any Private Placement Warrants issued to the Sponsor, officers or directors upon conversion of Working Capital
Loans; provided that such conversion of Founder Shares will never occur on a less than one-for-one basis.

Warrants

Warrants6 Months Ended
Jun. 30, 2021
Warrants [Abstract]
WARRANTSNOTE 7. WARRANTS Public Warrants may only be exercised for a whole
number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable
on the later of (a) 30 days after the completion of a Business Combination and (b) one year from the closing of the Initial
Public Offering. The Public Warrants will expire five years from the completion of a Business Combination or earlier upon redemption
or liquidation. The Company will not be obligated to deliver any
Class A ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless
a registration statement under the Securities Act with respect to the Class A ordinary shares underlying the warrants is then effective
and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration, or a valid
exemption from registration is available. No warrant will be exercisable and the Company will not be obligated to issue a Class A
ordinary share upon exercise of a warrant unless the Class A ordinary share issuable upon such warrant exercise has been registered,
qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. The Company has agreed that as soon as practicable,
but in no event later than 20 business days, after the closing of a Business Combination, it will use its best efforts to file with the
SEC a registration statement for the registration, under the Securities Act, of the Class A ordinary shares issuable upon exercise
of the warrants. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such
registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions
of the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants
is not effective by the sixtieth (60 th Redemption of warrants when the price per
Class A ordinary share equals or exceeds $18.00.
● in whole and not in part;
● at a price of $0.01 per warrant;
● upon not less than 30 days’ prior written notice of redemption to each warrant holder; and
● if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending three business days before the Company sends to the notice of redemption to the warrant holders (the “Reference Value”). If and when the warrants become redeemable by
the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale
under all applicable state securities laws. Redemption of warrants when the price per
Class A ordinary share equals or exceeds $10.00. ● in whole and not in part; ● at $0.10 per warrant ● upon not less than 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares based on the redemption date and the fair market value of the Class A ordinary shares except as otherwise described below; ● if, and only if, the Reference Value equals or exceeds $10.00 per Public Share (as adjusted) for any 20 trading days within the 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and ● if the Reference Value is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above. If the Company calls the Public Warrants for redemption,
as described above, its management will have the option to require any holder that wishes to exercise the Public Warrants to do so on
a “cashless basis,” as described in the warrant agreement. The exercise price and number of ordinary shares issuable upon
exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend
or recapitalization, reorganization, merger or consolidation. However, except as described below, the Public Warrants will not be adjusted
for issuances of ordinary shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash
settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company
liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public
Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such
Public Warrants. Accordingly, the Public Warrants may expire worthless. In addition, if (x) the Company issues additional
Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination
at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue
price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or
its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance)
(the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total
equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business
Combination (net of redemptions), and (z) the volume weighted average trading price of its Class A ordinary shares during the
20 trading day period starting on the trading day prior to the day on which the Company consummates its Business Combination (such price,
the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to
be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will
be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price and the $10.00 per
share redemption trigger price will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued
Share Price. The Private Placement Warrants are identical to
the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A
ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days
after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will
be exercisable on a cashless basis and be non-redeemable, except as described above, so long as they are held by the initial purchasers
or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted
transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the
Public Warrants. As of June 30, 2021, the Company executed an agreement
whereby the holders of the private warrants will not transfer their warrants to non-affiliated holders. The private warrants are now considered
to be indexed to the Company’s ordinary shares in the manner contemplated by ASC Section 815-40-15. Therefore, the Public and Private
Placement Warrants are accounted for as equity in the balance sheets.

Fair Value Measurements

Fair Value Measurements6 Months Ended
Jun. 30, 2021
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTSNOTE 8. FAIR VALUE MEASUREMENTS The Company classifies its U.S. Treasury and equivalent
securities as held-to-maturity in accordance with ASC Topic 320 “Investments - Debt and Equity Securities.” Held-to-maturity
securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities
are recorded at amortized cost on the accompanying balance sheet and adjusted for the amortization or accretion of premiums or discounts.
Securities invested in money market funds are recorded based on quoted market prices in active market. At June 30, 2021, assets held in the Trust Account
were comprised of $325,008,631 in money market funds which are invested primarily in U.S. Treasury Securities. At December 31, 2020 there
were no assets held in the Trust Account. Through June 30, 2021, the Company did not withdraw any interest income from the Trust Account. The following table presents information about
the Company’s assets and liabilities that are measured at fair value on a recurring basis at June 30, 2021 and indicates the fair
value hierarchy of the valuation inputs the Company utilized to determine such fair value:
Description Level June 30, December 31,
Assets:
Investments held in Trust Account 1 $ 325,008,631 $ —
Liabilities:
Warrant Liability – Private Placement Warrants 3 $ — $ 2,790,000 The Private Placement Warrants were accounted for
as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities in the condensed balance sheets at December
31, 2021 There was no warrant liability at June 30, 2021. The warrant liabilities were measured at fair value
at inception and on a recurring basis, with changes in fair value presented in the condensed statements of operations. As of June 30,
2021, the Company executed an agreement whereby the holders of the private warrants will not transfer their warrants to non-affiliated
holders. The private warrants are now considered to be indexed to the Company’s ordinary shares in the manner contemplated by ASC
Section 815-40-15 and therefore qualify for equity treatment. At June 30, 2021, the Private Placement Warrants were valued using the Public
Warrant price right before they were transferred into equity. The Private Placement Warrants were valued using
a Modified Black-Scholes model, which is considered to be a Level 3 fair value measurement. However, inherent uncertainties are involved.
If factors or assumptions change, the estimated fair values could be materially different. The Modified Black-Scholes model’s primary
unobservable input utilized in determining the fair value of the Private Placement Warrants is the expected volatility of the ordinary
shares. The expected volatility was derived from observable public warrant pricing on comparable ‘blank-check’ companies without
an identified target. The expected volatility as of subsequent valuation dates was implied from the Company’s own Public Warrant
pricing.
January 12, December 31,
Exercise price $ 11.50 $ 11.50
Stock price $ 10.00 $ 10.00
Expected volatility 20.0 % 18.0 %
Expected Term 5.00 5.00
Risk-free interest rate 0.50 % 0.36 %
Dividend yield 0.00 % 0.0 %
Probability of Business Combination 80.0 % 80.0 % The following table presents the changes in the
fair value of Level 3 warrant liabilities:
Private
Fair value as of December 31, 2020 $ 2,790,000
Initial measurement of 500,000 Private Placement Warrants issued on January 12, 2021 (Initial Public Offering) 530,000
Cancellation of 2,583,333 Private Placement Warrants (930,000 )
Change in fair value 3,730,000
Fair value as of March 31, 2021 6,120,000
Change in fair value (736,666 )
Transfer to Equity (5,383,334 )
Fair value as of June 30, 2021 — Transfers to/from Levels 1, 2 and 3 are recognized
at the beginning of the reporting period in which a change in valuation technique or methodology occurs. As of June 30, 2021, the balance
of the Private Placement Warrant liability was transferred to equity as discussed above.

Subsequent Events

Subsequent Events6 Months Ended
Jun. 30, 2021
Subsequent Events [Abstract]
SUBSEQUENT EVENTSNOTE 9. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions
that occurred after the balance sheet date up to the date that the condensed financial statements were issued. Based upon this review,
the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)6 Months Ended
Jun. 30, 2021
Accounting Policies [Abstract]
Basis of PresentationBasis of Presentation The accompanying unaudited condensed financial
statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”)
for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain
information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or
omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information
and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management,
the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are
necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial
statements should be read in conjunction with the Company’s Annual Report on Form 10-K, as amended on July 26, 2021, for the period
ended December 31, 2020. The interim results for the three and six months ended June 30, 2021 are not necessarily indicative of the results
to be expected for the year ending December 31, 2021 or for any future periods.
Emerging Growth CompanyEmerging Growth Company The Company is an “emerging growth company,”
as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”),
and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that
are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting
firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation
in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive
compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts
emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that
is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered
under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company
can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but
any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that
when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging
growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison
of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth
company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting
standards used.
Use of EstimatesUse of Estimates The preparation of the condensed financial statements
in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of
assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts
of revenues and expenses during the reporting period. Making estimates requires management to exercise
significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances
that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near
term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed financial
statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information
becomes available and accordingly the actual results could differ significantly from those estimates.
Cash and Cash EquivalentsCash and Cash Equivalents The Company considers all short-term investments
with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents
as of June 30, 2021 and December 31, 2020.
Offering CostsOffering Costs Offering costs consisted of legal, accounting
and other expenses incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs
were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared
to total proceeds received. Offering costs associated with warrant liabilities were expensed as incurred in the condensed statements of
operations. Offering costs associated with the Class A ordinary shares issued were charged to shareholders’ equity upon the completion
of the Initial Public Offering. Offering costs amounting to $18,391,778 were charged to shareholders’ equity upon the completion
of the Initial Public Offering. The Company’s deferred underwriting commissions are classified as non-current liabilities as their
liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. 
Class A Ordinary Shares Subject to Possible RedemptionClass A Ordinary Shares Subject to Possible
Redemption The Company accounts for its Class A ordinary
shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480
“Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption are classified as a liability
instrument and are measured at redemption value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption
rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within
the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’
equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s
control and subject to occurrence of uncertain future events. Accordingly, at June 30, 2021, Class A ordinary shares subject to possible
redemption are presented as temporary equity, outside of the shareholders’ equity section of the Company’s condensed balance
sheet. 
Warrant LiabilitiesWarrant Liabilities The Company does not use derivative instruments
to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including
issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives,
pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The Company accounts for the
Public Warrants and Private Placement Warrants (together with the Public Warrants, the “Warrants”) in accordance with the
guidance contained in ASC 815-40. Previously, the Private Placement Warrants did not meet the criteria for equity treatment and were recorded
as liabilities. Accordingly, the Company classified the Private Placement Warrants as liabilities at their fair value and adjusted the
Private Placement Warrants to fair value at each reporting period. This liability was subject to re-measurement at each balance sheet
date until exercised, and any change in fair value was recognized in our statements of operations. The Private Placement Warrants for
periods where no observable traded price was available were valued using a Modified Black-Scholes model. As of June 30, 2021, the Company
executed an agreement whereby the holders of the private warrants will not transfer their warrants to non-affiliated holders. The private
warrants are now considered to be indexed to the Company’s ordinary shares in the manner contemplated by ASC Section 815-40-15 and
therefore qualify for equity treatment.
Income TaxesIncome Taxes The Company accounts for income taxes under ASC
Topic 740, “Income Taxes,” which prescribes a recognition threshold and a measurement attribute for the financial statement
recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax
position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined
that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to
unrecognized tax benefits as income tax expense. As of June 30, 2021 and December 31, 2020, there were no unrecognized tax benefits and
no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant
payments, accruals or material deviation from its position. The Company’s management does not expect the total amount of unrecognized
tax benefits will materially change over the next twelve months. The Company is considered to be an exempted Cayman
Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing
requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented.
Net income (Loss) per Ordinary ShareNet income (Loss) per Ordinary Share Net income (loss) per ordinary share is computed
by dividing net income (loss) by the weighted average number of ordinary shares outstanding for the period. The calculation of diluted
income (loss) per share does not consider the effect of the warrants issued in connection with the Initial Public Offering and the private
placement , since the average stock price of the Company’s ordinary shares for the three and six months ended June 30, 2021 was less
than the exercise price and therefore, the inclusion of such warrants under the treasury stock method would be anti-dilutive. The Company’s statements of operations include
a presentation of income (loss) per share for ordinary shares subject to possible redemption in a manner similar to the two-class method
of income (loss) per ordinary share. Net income (loss) per ordinary share, basic and diluted, for Class A redeemable ordinary shares is
calculated by dividing the interest income earned on the Trust Account, by the weighted average number of Class A redeemable ordinary
shares outstanding since original issuance. Net income (loss) per share, basic and diluted, for Class B non-redeemable ordinary shares
is calculated by dividing the net income (loss), adjusted for income attributable to Class A redeemable ordinary shares, by the weighted
average number of Class B non-redeemable ordinary shares outstanding for the period. Class B non-redeemable ordinary shares includes the
Founder Shares as these shares do not have any redemption features and do not participate in the income earned on the Trust Account. The following table reflects the calculation of
basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts):
Three Months Six Months June 30,
2021 2021
Redeemable Class A Ordinary Shares
Numerator: Earnings allocable to Redeemable Class A Ordinary Shares
Interest Income $ 4,940 $ 8,631
Redeemable Net Earnings $ 4,940 $ 8,631
Denominator: Weighted Average Redeemable Class A Ordinary Shares (1)
Redeemable Class A Ordinary Shares, Basic and Diluted 32,500,000 32,500,000
Earnings/Basic and Diluted Redeemable Class A Ordinary Shares $ 0.00 $ 0.00
Non-Redeemable Class A and B Ordinary Shares
Numerator: Net Income (Loss) minus Redeemable Net Earnings
Net Income (Loss) $ 444,499 $ (3,621,689 )
Less: Redeemable Net Earnings (4,940 ) (8,631 )
Non-Redeemable Net Income (Loss) $ 439,559 $ (3,630,320 )
Denominator: Weighted Average Non-Redeemable B Ordinary Shares
Non-Redeemable B Ordinary Shares, Basic and Diluted 8,125,000 8,076,657
Basic and Diluted Net Income (Loss) Per Share, Non-Redeemable Class A and
B Ordinary Shares $ 0.05 $ (0.45 )
(1) For the three and six months ended June 30, 2021, basic and diluted
ordinary shares are the same as there are no non-redeemable securities that are dilutive to the Company’s shareholders.
Concentration of Credit RiskConcentration of Credit Risk Financial instruments that potentially subject
the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal
Depository Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on these accounts and management believes
the Company is not exposed to significant risks on such account.
Fair Value of Financial InstrumentsFair Value of Financial Instruments The fair value of the Company’s financial
assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale
of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the
measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of
observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions
about how market participants would price assets and liabilities). Carrying values for prepaids, accounts payable and accrued expenses
approximate fair value. The following fair value hierarchy is used to
classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.
Derivative Financial InstrumentsDerivative Financial Instruments The Company evaluates its financial instruments
to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic
815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative
instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the
fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments
should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified
in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required
within 12 months of the balance sheet date.
Recent Accounting StandardsRecent Accounting Standards In August 2020, the Financial Accounting Standards
Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other
Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”)
to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial
conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining
to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible
debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings
per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is for fiscal
years beginning after December 15, 2021 and should be applied on a full or modified retrospective basis. Early adoption is permitted,
but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company is
currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows. Management does not believe that any other recently
issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed
financial statements.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Tables)6 Months Ended
Jun. 30, 2021
Accounting Policies [Abstract]
Schedule of basic and diluted net income (loss) per ordinary shareThree Months Six Months June 30,
2021 2021
Redeemable Class A Ordinary Shares
Numerator: Earnings allocable to Redeemable Class A Ordinary Shares
Interest Income $ 4,940 $ 8,631
Redeemable Net Earnings $ 4,940 $ 8,631
Denominator: Weighted Average Redeemable Class A Ordinary Shares (1)
Redeemable Class A Ordinary Shares, Basic and Diluted 32,500,000 32,500,000
Earnings/Basic and Diluted Redeemable Class A Ordinary Shares $ 0.00 $ 0.00
Non-Redeemable Class A and B Ordinary Shares
Numerator: Net Income (Loss) minus Redeemable Net Earnings
Net Income (Loss) $ 444,499 $ (3,621,689 )
Less: Redeemable Net Earnings (4,940 ) (8,631 )
Non-Redeemable Net Income (Loss) $ 439,559 $ (3,630,320 )
Denominator: Weighted Average Non-Redeemable B Ordinary Shares
Non-Redeemable B Ordinary Shares, Basic and Diluted 8,125,000 8,076,657
Basic and Diluted Net Income (Loss) Per Share, Non-Redeemable Class A and
B Ordinary Shares $ 0.05 $ (0.45 )

Fair Value Measurements (Tables

Fair Value Measurements (Tables)6 Months Ended
Jun. 30, 2021
Fair Value Disclosures [Abstract]
Schedule of financial assets and liabilities that are measured at fair value on a recurring basisDescription Level June 30, December 31,
Assets:
Investments held in Trust Account 1 $ 325,008,631 $ —
Liabilities:
Warrant Liability – Private Placement Warrants 3 $ — $ 2,790,000
Schedule of fair value measurements inputsJanuary 12, December 31,
Exercise price $ 11.50 $ 11.50
Stock price $ 10.00 $ 10.00
Expected volatility 20.0 % 18.0 %
Expected Term 5.00 5.00
Risk-free interest rate 0.50 % 0.36 %
Dividend yield 0.00 % 0.0 %
Probability of Business Combination 80.0 % 80.0 %
Schedule of changes in the fair value of Level 3 warrant liabilitiesPrivate
Fair value as of December 31, 2020 $ 2,790,000
Initial measurement of 500,000 Private Placement Warrants issued on January 12, 2021 (Initial Public Offering) 530,000
Cancellation of 2,583,333 Private Placement Warrants (930,000 )
Change in fair value 3,730,000
Fair value as of March 31, 2021 6,120,000
Change in fair value (736,666 )
Transfer to Equity (5,383,334 )
Fair value as of June 30, 2021 —

Description of Organization a_2

Description of Organization and Business Operations (Details) - USD ($)Jan. 12, 2021Jun. 30, 2021
Description of Organization and Business Operations (Details) [Line Items]
Shares of initial public offering (in Shares)32,500,000
Amount of gross proceeds $ 325,000,000
Transaction costs $ 18,391,778
Amount of underwriting fees6,500,000
Deferred underwriting fees11,375,000
Other offering costs $ 516,778
Net proceeds from sale of initial public offering $ 325,000,000
Business combination fair value market percentage80.00%
Business combination percentage50.00%
Public share price per share (in Dollars per share) $ 10
Net tangible assets $ 5,000,001
Public shares, percentage15.00%
Percentage of business combination redeemed shares100.00%
Consummate business combination, descriptionHowever, if the Company has not completed a Business Combination
within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly
as reasonably possible but not more than ten business days thereafter, redeem 100% of the Public Shares, at a per-share price, payable
in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned and not previously released to
us to pay our taxes, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding
Public Shares, which redemption will completely extinguish the rights of the Public Shareholders as shareholders (including the right
to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject
to the approval of the Company’s remaining Public Shareholders and its Board of Directors, liquidate and dissolve, subject in each
case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable
law.
Description of prospective target business(1) $10.00 per Public Share and (2) the actual amount per Public Share held in the Trust Account as of
the date of the liquidation of the Trust Account, if less than $10.00 per Public Share, due to reductions in the value of trust assets,
in each case net of the interest that may be withdrawn to pay taxes. This liability will not apply to any claims by a third party who
executed a waiver of any and all rights to seek access to the Trust Account and as to any claims under the Company’s indemnity of
the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as
amended (the “Securities Act”).
Operating bank accounts $ 748,858
Working capital $ 866,236
Over-Allotment Option [Member]
Description of Organization and Business Operations (Details) [Line Items]
Shares issued (in Shares)2,500,000
Share price (in Dollars per share) $ 10
IPO [Member]
Description of Organization and Business Operations (Details) [Line Items]
Share price (in Dollars per share) $ 10 $ 10

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details)6 Months Ended
Jun. 30, 2021USD ($)
Accounting Policies [Abstract]
Offering costs $ 18,391,778
Tax provision0
Federal depository insurance coverage $ 250,000

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted net income (loss) per ordinary share - USD ($)3 Months Ended6 Months Ended
Jun. 30, 2021Jun. 30, 2021
Numerator: Earnings allocable to Redeemable Class A Ordinary Shares
Interest Income (in Dollars) $ 4,940 $ 8,631
Redeemable Net Earnings (in Dollars) $ 4,940 $ 8,631
Denominator: Weighted Average Redeemable Class A Ordinary Shares (1)
Redeemable Class A Ordinary Shares, Basic and Diluted[1]32,500,000 32,500,000
Earnings/Basic and Diluted Redeemable Class A Ordinary Shares (in Dollars per share)[1] $ 0 $ 0
Numerator: Net Income (Loss) minus Redeemable Net Earnings
Net Income (Loss) (in Dollars) $ 444,499 $ (3,621,689)
Less: Redeemable Net Earnings(4,940)(8,631)
Non-Redeemable Net Income (Loss)439,559 (3,630,320)
Denominator: Weighted Average Non-Redeemable B Ordinary Shares
Non-Redeemable B Ordinary Shares, Basic and Diluted8,125,000 8,076,657
Basic and Diluted Net Income (Loss) Per Share, Non-Redeemable Class A and B Ordinary Shares (in Dollars per share) $ 0.05 $ (0.45)
[1]For the three and six months ended June 30, 2021, basic and diluted ordinary shares are the same as there are no non-redeemable securities that are dilutive to the Company’s shareholders.

Initial Public Offering (Detail

Initial Public Offering (Details)6 Months Ended
Jun. 30, 2021$ / sharesshares
Initial Public Offering (Details) [Line Items]
Public warrant descriptionEach Unit consists of one Class A ordinary share and one-third of one redeemable warrant
(“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at an exercise
price of $11.50 per whole share (see Note 7).
Initial Public Offering [Member]
Initial Public Offering (Details) [Line Items]
Sale of stock32,500,000
Over-Allotment Option [Member]
Initial Public Offering (Details) [Line Items]
Sale of stock2,500,000
Exercise price (in Dollars per share) | $ / shares $ 10

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)Jan. 07, 2021Jan. 31, 2021Jan. 22, 2021Dec. 16, 2020Sep. 28, 2020Jun. 30, 2021Mar. 31, 2021Jun. 30, 2021Dec. 31, 2021Dec. 31, 2020Sep. 18, 2020
Related Party Transactions (Details) [Line Items]
Aggregate purchased shares (in Shares)2,583,333
Private placement warrants, shares (in Shares)2,300,000 10,050,000
Aggregate purchase price $ 10,075,000 $ 306,608,222
Sponsor returned founder shares (in Shares)2,875,000
Private placement warrants amount $ 2,300,000
Related party transactions, descriptionthe Sponsor forfeited an additional 2,583,333 Private Placement Warrants for no consideration,
resulting in 7,187,500 Founder Shares and 5,166,667 Private Placement Warrants outstanding. On January 7, 2021, the Company effected a
1:1.2 share capitalization of its Class B ordinary shares, resulting in an aggregate of 8,625,000 Founder Shares outstanding, all of which
are held by the Sponsor.
Aggregate purchased share (in Shares)500,000
Aggregate purchase amount $ 750,000
Aggregate purchase price per share (in Dollars per share) $ 1.50
Subject forfeiture share (in Shares)1,125,000
Percentage of issued and outstanding20.00%
Warrant exercisable, descriptionEach Private Placement Warrant is exercisable
to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 7).
Stock splits, descriptionThe Sponsor has agreed, subject to limited exceptions,
not to transfer, assign or sell any of the Founder Shares until the earliest of: (A) one year after the completion of a Business
Combination and (B) subsequent to a Business Combination, (x) if the closing price of the Class A ordinary shares equals
or exceeds $12.00 per share (as adjusted for share sub-divisions, share dividends, rights issuances, reorganizations, recapitalizations
and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination,
or (y) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in
all of the Public Shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property. 
Sponsor amount $ 10,000
Company incurred and paid $ 30,000 $ 60,000
Accounts payable and accrued expenses $ 60,000 60,000 $ 60,000
Aggregate principal amount $ 300,000
Promissory note amount $ 10,000
Working capital loans $ 1,500,000
Post Business Combination [Member]
Related Party Transactions (Details) [Line Items]
Business combination entity at a price per warrant (in Dollars per share) $ 1.50 $ 1.50
Founder Shares [Member]
Related Party Transactions (Details) [Line Items]
Aggregate purchased shares (in Shares)10,062,500
Common stock, shares outstanding (in Shares)500,000 500,000
Class B Ordinary Shares [Member]
Related Party Transactions (Details) [Line Items]
Common stock, shares outstanding (in Shares)8,125,000 8,125,000 8,625,000
Common stock, shares issued (in Shares)8,125,000 8,125,000 8,625,000
Class B Ordinary Shares [Member] | Founder Shares [Member]
Related Party Transactions (Details) [Line Items]
Remaining option share, descriptionAs a result of the underwriters’ election to partially
exercise their over-allotment option and the forfeiture of the remaining option, 500,000 Founder Shares were forfeited and there are now
8,125,000 Class B ordinary shares issued and outstanding.
Common stock, shares issued (in Shares)8,125,000 8,125,000

Commitments and Contingencies (

Commitments and Contingencies (Details)6 Months Ended
Jun. 30, 2021USD ($)$ / shares
Commitments and Contingencies Disclosure [Abstract]
Deferred fee, per unit | $ / shares $ 0.35
Deferred underwriting fees | $ $ 11,375,000

Shareholders' Equity (Details)

Shareholders' Equity (Details) - $ / shares6 Months Ended
Jun. 30, 2021Dec. 31, 2020
Shareholders' Equity (Details) [Line Items]
Preferred stock, shares authorized1,000,000 1,000,000
Preferred stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Class A Ordinary Shares [Member]
Shareholders' Equity (Details) [Line Items]
Common stock, shares authorized200,000,000 200,000,000
Common stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Common stock, shares issued1,550,014
Shares subject to possible redemption30,949,986
Common stock, shares outstanding1,550,014
Public warrants redemption, descriptionIn the case that additional Class A ordinary shares or equity-linked securities are issued or deemed
issued in connection with a Business Combination, the number of Class A ordinary shares issuable upon conversion of all Founder Shares
will equal, in the aggregate, 20% of the total number of Class A ordinary shares outstanding after such conversion (after giving
effect to any redemptions of Class A ordinary shares by Public Shareholders), including the total number of Class A ordinary
shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued,
by the Company in connection with or in relation to the consummation of a Business Combination, excluding any Class A ordinary shares
or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller in
a Business Combination and any Private Placement Warrants issued to the Sponsor, officers or directors upon conversion of Working Capital
Loans; provided that such conversion of Founder Shares will never occur on a less than one-for-one basis.
Aggregate shares outstanding, percentage20.00%
Class B Ordinary Shares [Member]
Shareholders' Equity (Details) [Line Items]
Common stock, shares authorized20,000,000 20,000,000
Common stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Common stock, shares issued8,125,000 8,625,000
Common stock, shares outstanding8,125,000 8,625,000

Warrants (Details)

Warrants (Details)6 Months Ended
Jun. 30, 2021
Warrants (Details) [Line Items]
Redemption of outstanding warrants, descriptionRedemption of warrants when the price per
Class A ordinary share equals or exceeds $10.00. Once the warrants become exercisable, the Company may redeem the outstanding
warrants:  ●in whole and not in part;    ●at $0.10 per warrant    ●upon not less than 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares based on the redemption date and the fair market value of the Class A ordinary shares except as otherwise described below;    ●if, and only if, the Reference Value equals or exceeds $10.00 per Public Share (as adjusted) for any 20 trading days within the 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and    ●if the Reference Value is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above.
Business Combination, descriptionIn addition, if (x) the Company issues additional
Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination
at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue
price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or
its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance)
(the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total
equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business
Combination (net of redemptions), and (z) the volume weighted average trading price of its Class A ordinary shares during the
20 trading day period starting on the trading day prior to the day on which the Company consummates its Business Combination (such price,
the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to
be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will
be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price and the $10.00 per
share redemption trigger price will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued
Share Price. 
Warrant [Member]
Warrants (Details) [Line Items]
Redemption of warrants, descriptionRedemption of warrants when the price per
Class A ordinary share equals or exceeds $18.00. Once the warrants become exercisable, the Company may call the warrants for redemption
(except as described with respect to the Private Placement Warrants): 

 

in whole and not in part;

 
 
 

 

at a price of $0.01 per warrant;

 
 
 

 

upon not less than 30 days’ prior written notice of redemption to each warrant holder; and

 
 
 

 

if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending three business days before the Company sends to the notice of redemption to the warrant holders (the “Reference Value”).
 If and when the warrants become redeemable by
the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale
under all applicable state securities laws. 

Fair Value Measurements (Detail

Fair Value Measurements (Details)Jun. 30, 2021USD ($)
Fair Value Disclosures [Abstract]
Assets held in trust account $ 325,008,631

Fair Value Measurements (Deta_2

Fair Value Measurements (Details) - Schedule of financial assets and liabilities that are measured at fair value on a recurring basis - USD ($)Jun. 30, 2021Dec. 31, 2020
Level 1 [Member]
Assets:
Investments held in Trust Account $ 325,008,631
Level 3 [Member]
Liabilities:
Warrant Liability – Private Placement Warrants $ 2,790,000

Fair Value Measurements (Deta_3

Fair Value Measurements (Details) - Schedule of fair value measurements inputs - $ / sharesJan. 12, 2021Dec. 31, 2020
Schedule of fair value measurements inputs [Abstract]
Exercise price (in Dollars per share) $ 11.50 $ 11.50
Stock price (in Dollars per share) $ 10 $ 10
Expected volatility20.00%18.00%
Expected Term5 years5 years
Risk-free interest rate0.50%0.36%
Dividend yield0.00%0.00%
Probability of Business Combination80.00%80.00%

Fair Value Measurements (Deta_4

Fair Value Measurements (Details) - Schedule of changes in the fair value of Level 3 warrant liabilities - USD ($)3 Months Ended
Jun. 30, 2021Mar. 31, 2021
Schedule of changes in the fair value of Level 3 warrant liabilities [Abstract]
Fair value at beginning $ 6,120,000 $ 2,790,000
Initial measurement of 500,000 Private Placement Warrants issued on January 12, 2021 (Initial Public Offering) $ 530,000
Cancellation of 2,583,333 Private Placement Warrants (in Shares)(930,000)
Change in fair value(736,666) $ 3,730,000
Transfer to Equity(5,383,334)
Fair value at ending $ 6,120,000

Fair Value Measurements (Deta_5

Fair Value Measurements (Details) - Schedule of changes in the fair value of Level 3 warrant liabilities (Parentheticals)3 Months Ended
Mar. 31, 2021shares
Schedule of changes in the fair value of Level 3 warrant liabilities [Abstract]
Private placement warrants issued500,000
Cancellation of private placement warrants2,583,333